APMD Apnimed
Apnimed earnings company data as of 4:51 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 8 Dec | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 8 Sep | EPS | — | -6.80 | — |
| Rev | — | $81.3M | — |
Insider trades
Open-market buys and sales by APMD's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $5.2M bought by 2 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Morningside Venture Investments Ltd 10% ownerBuy$5M 312,500 shares at $16.00 +4.6% to stakeTraded Aug 3 Filed Aug 5
-
Paul J Sekhri DirectorBuy$200K 12,500 shares at $16.00 New stakeTraded Aug 3 Filed Aug 3
Also filed in the last 12 months, not counted as buying or selling: 7 conversions, 6 stock grants, 6 sales back to the company, and 4 other transactions.
SEC filings
Recent issuer filings from EDGAR, 8 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.